Summary
Evidence points to glomerular fibrin deposition (GFD) as an important mediator of renal injury and crescent formation. GFD appears to be initiated by intraglomerular stimuli related to local immune inflammatory events. Macrophages expressing augmented procoagulant activity (PCA) are likely to be important initiators of GFD. Antibody Fc direction or delayed type hypersensitivity (DTH) mechanisms may be the primary initiating event. Other factors, including contact activation of coagulation and inhibition of fibrinolytic clearance, may act in concert to exacerbate fibrin accumulation, especially in Bowman’s space. The importance of GFD in human GN is highlighted by evidence that it may be prevented or reversed by therapeutic intervention, thereby offering the potential for limiting the progression of injury in these forms of GN.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kincaid-Smith P (1972) Coagulation and renal disease. Kidney Int 2: 183–190
McCluskey RT, Vassalli P, Gallo G, Baldwin DS (1966) An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med 274: 695–701
Naish P, Penn GB, Evans DJ, Peters, DK (1972). The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 42: 643–646
Naish PF, Evans DJ, Peters DK (1975) The effects of defibrination with ancrod in experimental allergic glomerular injuries. Clin Exp Immunol 20: 303–309
Thomson NM, Simpson IJ, Evans DJ, Peters, DK (1975) Defibrination with ancrod in experimental chronic immune complex nephritis. Clin Exp Immunol 20: 527–535
Tipping PG, Holdsworth SR (1986) Fibrinolytic therapy with streptokinase in established experimental glomerulonephritis. Nephron 43: 258–264
Tipping PG, Thomson NM, Holdsworth SR (1986) A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Brit J Exp Pathol 67: 481–491
Humair L, Kwann HC, Potter E (1969) The role of fibrinogen in renal disease II. Effects of anticoagulants and urokinase on experimental lesions in mice. J Lab Clin Med 74: 72–78
Tsumagari T, Tanaka K (1984) Effects of fibrinogen degradation products on glomerular mesangial cells in culture. Kidney Int 26: 712–718
Salem HH, Whitworth JA, Koutts J (1981) Hypercoagulation in glomerulonephritis. Br Med J 282: 2083–2086
Adhikari M, Coovadia HM, Greig HBW, Christensen S (1978) Factor VIII procoagulant activity in children with nephrotic syndrome and post-streptococcal glomerulonephritis. Nephron 22: 301–305
Esmon CT (1987) The regulations of natural anticoagulant pathways. Science 235: 1348–1352
Kendall AG, Lohmann RC, Dossetor JB Nephrotic syndrome a hypercoagulable state. Ann Intern Med 127: 1021–1031
Vaziri ND (1983) Nephrotic syndrome and coagulation and fibrinolytic abnormalities. Am J Nephrol 3: 1
Holdsworth SR, Tipping PG (1985) Macrophage induced fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest 76: 1367–1374
Hoyer JR, Michael AF, Hoyer LW (1974) Immunofluorescent localization of antihemophiliac factor antigen and fibrinogen in human renal disease. J Clin Invest 53: 1375–1384
Villaro J, Errasti P, Goni M, Monzo A, Purroy A, Sanchez-Ibarrola A (1984) Pathogenesis of glomerular fibrin deposition: Role of the contact system (abstract). Kidney Int 26: 219
Wiggins RG (1985) Hageman factor in experimental nephrotoxic nephritis in the rabbit. Lab Invest 53: 335–348
Tipping PG, Holdsworth SR (1986) The participation of macrophages, glomerular procoagulant activity and factor VIII in glomerular fibrin deposition. Studies in antiglomerulonephritis basement membrane antibody induced glomerulonephritis in rabbits. Am J Pathol 124: 10–17
George CPR, Clark WF, Cameron JS (1975) The role of platelets in glomerulonephritis. Adv Nephrol 5: 19–65
Vassali P, McCluskey RT (1964) The pathogenic role of the coagulation process in rabbit Masugi nephritis. Am J Path 45: 653–677
Gabbiani G, Boadonnel MC, Vassoli P (1975) Experimental focal glomerular lesion elicited by insoluble immune complexes: ultrastructural and immunofluorescent studies. Lab Invest 32: 33–45
Ogawa S, Naruse T (1982) Effects of various antiplatelet drugs and a defibrinating agent on experimental glomerulonephritis in rats. J Lab Clin Med 99: 428–435
Sindrey M, Marshall TI, Naish P (1979) Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin Exp Immunol 36: 90–96
Atkins RC, Holdsworth SR, Glasgow EF, Matthews FE (1976) The macrophage in human rapidly progressive glomerulonephritis. Lancet 1: 830–832
Monga G, Mazzucco G, Barbiano di Belgiojoso GB, Busnach G (1979) The presence and possible role of monocyte infiltration in human chronic proliferative glomerulonephritides. Light microscopic, immunofluorescence and histochemical correlation. Am J Pathol 94: 271–284
Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgiojoso G, Bertoli S, D’Amico G (1985) The detection of monocytes in human glomerulonephritis. Kidney Int 28: 513–519
Magil AB, Wadsworth AB (1981) Monocytes in human glomerulonephritis. An electromicroscopic study. Lab Invest 34: 77–81
Tipping PG, Worthington LA, Holdsworth SR (1987) The quantitation and characterization of glomerular procoagulant activity in experimental glomerulonephritis. Lab Invest 56: 155–159
Tipping PG, Lowe MG, Holdsworth SR (1988) Glomerular macrophages express augmented procoagulant activity in experimental glomerulonephritis in rabbits. J Clin Invest 82: 1253–1259
Cotran RS (1987) New roles for the endothelium in inflammation and immunity. Am J Pathol 129: 407–413
Bevilacqua MP, Schleef RR, Gimbrone MA, Loskutoff DJ (1986) Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 78: 581–591
Mulfelder TW, Niemetz J, Kreutzer D, Beebe D, Ward PA, Rosenfeld SI (1979) C5 chemotactic fragment induces leukocyte production of tissue factor activity: A link between complement and coagulation. J Clin Invest 63: 147–150
Rothberger H. Zimmerman TS, Spiegleberg HL, Vaughan JH (1977) Leukocyte pro-coagulant activity. Enhancement of production “in vitro” by IgG and antigen-antibody complexes. J Clin Invest 59: 549–557
Schwartz BS, Edgington TS (1981) Immune complex-induced human monocyte procoagulant activity. I. A rapid unidirectional lymphocyte instructed pathway. J Exp Med 154: 892–906
Edwards RL, Rickles FR, Bolorove AM (1979) Mononuclear cell tissue factor. Cell of origin and requirements for activation. Blood 54: 359–370
Helin H, Edgington TS (1983) Allogenic induction of the human T cell instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med 58: 962–975
Gregory SM, Edgington TS (1985) Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest 76: 2440–2445
Tipping PG, Neale TJ, Holdsworth SR (1985) T-lymphocyte participation in antibody induced experimental glomerulonephritis. Kidney Int 27: 530–537
Stachura I, Si L, Whiteside TL (1984) Mononuclear cell subsets in human idiopathic crescentic glomerulonephritis: Analysis in tissue sections with monoclonal antibodies. J Clin Immunol 4: 203–208
Nolasco FEB, Cameron JS, Hartley B, Coelho A, Hildreth G, Reuben R (1987) Intraglomerular T cells and monocytes in nephritis: Study with monoclonal antibodies. Kidney Int 31: 1160–1166
Neale TJ, Tipping PG, Carson S, Holdsworth SR (1988) Evidence for the participation of cell mediated immunity in the deposition of fibrin in glomerulonephritis. Lancet 11: 421–424
Baud L, Sraer J, Delarue F, Bens M, Balavoine F, Schlondorff D, Ardaillou R, Sraer JD (1985) Lipoxygenase products mediate the attachment of rat macrophages to glomeruli in vitro. Kidney Int 27: 855–863
Wiggins RC, Njoku N, Sedor JR (1990) Tissue factor production by cultured rat mesangial cells. Stimulation by TNFu and lipopolysaccharide. Kidney Int 37: 1281–1285
Boswell JM, Tui MA, Burt DW, Kelly VE (1988) Increased tumor necrosis factor and IL1–13 gene expression in the kidneys of mice with lupus nephritis. J Immunol 141: 3052–3054
Angles Cano E, Balaton A, Le Bonniec B, Genot E, Elion J, Sultan Y (1985) Production and immunolocalization of monoclonal antibodies to the high fibrin affinity tissue type plasminogen activator of human plasma: Demonstration of its endothelial origin by immunolocalization. Blood. 66: 913–920
Hancock WW (1990) IL and TNF depress glomerular endothelial thrombomodulin expression in vitro and in vivo (abstract). Kidney Int 38: 557.
Sraer JD, Kanfer A, Rondeau E, Lacaux R (1988) Glomerular hemostasis in normal and pathologic conditions. Adv Nephrol 17: 27–56
Tipping PG, Lowe MG, Holdsworth SR (1991) Glomerular interleukin I production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int (in press)
Stark H, Miller K, Michael AF (1979) Renal cortical fibrinolytic activity in rabbits with chronic immune complex nephritis. Isr J Med Sci 14: 610–612
Giroux L, Verroust P, Morel-Maroger L, Delarue F, Delauche M, Sraer JD (1979) Glomerular fibrinolytic activity during nephrotoxic nephritis. Lab Invest 40: 415–422
Kanter A, De Prost D, Le Floch V (1985) Procoagulant activity in isolated glomeruli from normal and glomerulonephritic rats (abstract). Eur J Clin Invest 15: A43.
Clark BE, Ham KN, Tange JD, Ryan GB (1983) Macrophages and glomerular crescent formation: Studies with rat nephrotoxic nephritis. Pathology 15: 75–81
Kanter A, de Prost D, Guettier C, Nochy D, Le Floch V, Hinglais N, Druet P (1987) Enhanced glomerular procoagulant activity and fibrin deposition in rats with mercuric chloride-induced autoimmune nephritis. Lab Invest 57: 138–143
Ekberg M, Pandolli M (1975) Origin of urinary fibrin fibrinogen degradation products in glomerulonephritis. Br Med J [Clin Res] 2: 17–21
Clarkson AR, McDonald MK, Petrie JJB, Cash JD, Robson JS (1971) Serum and urine fibrin/fibrinogen degradation products in glomerulonephritis. Br Med J [Clin Res] 3: 447–451
Tipping PG, Dowling JP, Holdsworth SR (1988) Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81: 119–125
Bergstein JM, Michael AF (1972) Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med 79: 701–709
Mougenot B, Rondeau E, Kruithof B, Sraer JD (1988) Presence of type 1 plasminogen activator inhibitor (PA1–1) in renal fibrin deposits in human pathological conditions (abstract) Kidney Int 33: 330
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Japan
About this chapter
Cite this chapter
Holdsworth, S.R., Tipping, P.G. (1991). Mechanisms of Glomerular Fibrin Deposition in Glomerulonephritis. In: Hatano, M. (eds) Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-35158-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-35158-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70074-6
Online ISBN: 978-3-662-35158-1
eBook Packages: Springer Book Archive